Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

Pharmacist-led type 2 diabetes reviews in GP practices improve patient outcomes

Pharmacist intervention led to better blood pressure, glycated haemoglobin and total cholesterol scores for patients with type 2 diabetes, study shows.

Type 2 diabetes (T2D) is a complex condition to manage and results in around £23.7bn a year in associated healthcare costs.

To improve the management of T2D, Slough Clinical Commissioning Group asked experienced pharmacists to lead a review programme in 13 GP surgeries, involving nearly 6,000 patients, between April 2013 and April 2014.

By the end of the project, the percentage of patients receiving all nine of the NICE-recommended key care processes increased from 46% to 58%. The proportion of patients above the recommended targets for glycated haemoglobin (HbA1c), blood pressure and total cholesterol was lower for all three parameters at project completion than they had been in the year preceding the project, according to the Quality and Outcomes Framework. The percentage of patients achieving targets in these parameters increased during the project but then diminished in the year after. 

Reporting in BMJ Open[1] (online, 3 March 2017), the authors recommend that investment in a pharmacist-led programme will ensure that NICE-recommended key care processes are implemented, reducing morbidity, mortality and healthcare costs.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202688

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.